Evidence map›Paper›PMID 36530659›Full record

ArticleFrontiers in public health2022

An interdisciplinary framework for derivation of occupational exposure limits.

Laura L Maurer, Melannie S Alexander, Ammie N Bachman, Fabian A Grimm, R Jeff Lewis, Colin M North, Nancy C Wojcik, Katy O Goyak

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura L MaurerExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Melannie S AlexanderExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Ammie N BachmanExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Fabian A GrimmExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
R Jeff LewisExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Colin M NorthExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Nancy C WojcikExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.
Katy O GoyakExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protecting the health and safety of workers in industrial operations is a top priority. One of the resources used in industry to ensure worker safety is the occupational exposure limit (OEL). OELs are derived from the assessment and interpretation of empirical data from animal and/or human studies. There are various guidelines for the derivation and implementation of OELs globally, with a range of stakeholders (including regulatory bodies, governmental agencies, expert groups and others). The purpose of this manuscript is to supplement existing guidance with learnings from a multidisciplinary team approach within an industry setting. The framework we present is similar in construct to other risk assessment frameworks and includes: (1) problem formulation, (2) literature review, (3) weight of evidence considerations, (4) point of departure selection/derivation, (5) application of assessment factors, and the final step, (6) derivation of the OEL. Within each step are descriptions and examples to consider when incorporating data from various disciplines such as toxicology, epidemiology, and exposure science. This manuscript describes a technical framework by which available data relevant for occupational exposures is compiled, analyzed, and utilized to inform safety threshold derivation applicable to OELs.

Indexed as

Occupational ExposureOccupational HealthHumansIndustryRisk AssessmentThreshold Limit Valuesassessment factors (AFs)literature reviewpoint of departure (POD)problem formulationrisk assessmentweight of evidence (WOE)

Identifiers

PMID36530659
PMCPMC9748553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.